COCH Envoy Medical, Inc.

NASDAQ
$6.70

Envoy Medical, Inc. (COCH) is expected to report earnings on February 4, 2027, after the market close. The consensus earnings estimate is a loss of $0.64 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -6.0% since its last earnings release on November 5, 2026.

Envoy Medical Beat Consensus Estimates
Thursday, November 5, 2026 · 7:00 AM ET
Earnings Date
4th Quarter, Dec 2026
Feb 4
Thursday · After Close
Earnings Whisper
-
vs ($0.64)
Rev est $60K
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $6.97

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Envoy Medical, Inc.

Envoy Medical Inc. is a medical technology company focused on fully implanted hearing devices. The company's primary device is the fully implanted Acclaim(R) cochlear implant. Envoy Medical Inc., formerly known as Anzu Special Acquisition Corp I, is headquartered in White Bear Lake, Minnesota.

Sector

Healthcare

Industry

Medical Appliances/Equipment

Charts powered in part by Lightweight Charts™ by TradingView.